Fig. 3.
Effect of various concentrations (0.001-0.1 µM) of idarubicin on the cell viability of MCF-7, SK-BR-3, and SK-OV-3 cells
*P-value<0.05 in comparison to the corresponding control group, ‡ P-value<0.05 in comparison to the MCF-7 cells treated with idarubicin at the same concentration, $ P-value<0.05 in comparison to the SK-BR-3 cells treated with idarubicin at the same concentration.